SULT1

SULT1 denotes a family of cytosolic sulfotransferases that catalyze PAPS-dependent transfer of sulfuryl groups to hydroxyl- or amino-containing endogenous compounds and xenobiotics^[1]. Sulfation commonly increases substrate water solubility and facilitates elimination while reducing biological activity, although some SULT-mediated reactions bioactivate procarcinogens to reactive electrophiles^[1][2]. Accordingly, SULT1 enzymes participate in drug and xenobiotic metabolism as well as regulation of hormones and neurotransmitters^[1][2]. Disease relevance is isoform-dependent, because altered sulfation can modify chemical exposure and signaling, while functional SULT1A1 polymorphisms have been associated with cancer risk and therapeutic response^[2][3]. Individual SULT1 isoforms are not functionally interchangeable: SULT1A1 has broad activity toward small phenolic compounds, whereas the closely related SULT1A3 preferentially recognizes monoamine neurotransmitters such as dopamine^[4]. Their tissue distributions also differ; SULT1A1 constitutes more than half of measured SULT protein in adult liver, where SULT1A3 is undetectable, whereas SULT1B1 and SULT1A3 are major forms in small intestine^[5]. SULT1E1 provides another distinct specialization by sulfating endogenous and synthetic estrogens, thereby increasing estrogen hydrosolubility and preventing sulfated estrogens from binding estrogen receptors^[6]. These substrate- and tissue-specific properties make isoform-resolved enzyme assays essential when studying SULT1-mediated metabolism, pharmacological interactions, or endocrine regulation^[4][5][6].